|
A1: the full patient identifier is (b)(4).A2, a3, a4, a5 and a6: the customer did not supply patient demographics such as age, date of birth, sex, weight, ethnicity or race.H3 and h6:
no hardware errors or other sample/assay issues were reported in conjunction with this event.System performance indicators such as system check, calibration and quality control were passing within specifications at the time of the event.The customer reported both samples were lithium heparin and one sample was not a full draw and customer unsure about sample mixing and sample was centrifuged on the line.According to access hstni instruction for use (ifu), part number c09448, it states: ¿¿the role of pre-analytical factors in laboratory testing has been described in a variety of published literature.Following blood collection tube manufacturers¿ specimen collection and handling recommendations are essential to reduce pre-analytical errors¿.Additionally, as per clsi "[clinical and laboratory standards institute]" guideline-gp44-a4: procedures for the handling and processing of blood specimens for common laboratory tests.4th edition, ¿if less blood than required is drawn, the excess amount of additive has the potential to adversely affect the accuracy of test results¿
a fse was dispatched to the customer's site.Field service engineer (fse) verified instrument hardware by running a system check, high sensitivity system check, carryover and low-level qc precision and reported all passed.No further issue was reported by the customer.In conclusion, the cause of the event is use-error as customer did not follow the sample handling instructions for use.Retrospective mdr submission under capa-001570.The complaint was reassessed using beckman coulter's revised mdr malfunction reportability methodology and was determined to be reportable.This report is being submitted as part of capa-001570 remediation activities.
|